HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.

Abstract
Plasminogen activator inhibitor-1 (PAI-1) is a unique type of serine protease inhibitor and one of the key regulators of tumor invasion and metastasis. The purpose of this study was to elucidate the effect of PAI-1 gene transfection on liver metastasis and its mechanism by using the human high liver metastasis pancreatic cancer cell line, SW1990. PAI-1-transfected SW1990 (SW/PAI-1) produced a significantly higher level of PAI-1 in supernatant than parental cells. While no difference was observed for the production of u-PA and u-PA activity in the supernatant, cell proliferation of SW/PAI-1 was slightly suppressed on the 7th day of incubation compared to parental cells. Cellular invasion, in vivo tumorigenesis in xenograft and liver metastasis were significantly suppressed in SW/PAI-1 cells compared to parental cells. The angiogenesis of xenograft by detecting microvascular density and the production of metastasis-related factors, such as VEGF and TGF-beta1, were also decreased in SW/PAI-1 cells. These findings suggested that PAI-1 gene transfection might have the ability to prevent the liver metastasis of pancreatic cancer by modulating angiogenesis.
AuthorsMasafumi Inoue, Tetsuji Sawada, Yasutake Uchima, Kenjiro Kimura, Tamahiro Nishihara, Hiroaki Tanaka, Masakazu Yashiro, Nobuya Yamada, Masaichi Ohira, Kosei Hirakawa
JournalOncology reports (Oncol Rep) Vol. 14 Issue 6 Pg. 1445-51 (Dec 2005) ISSN: 1021-335X [Print] Greece
PMID16273237 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Culture Media, Conditioned
  • Plasminogen Activator Inhibitor 1
  • Platelet Endothelial Cell Adhesion Molecule-1
  • TGFB1 protein, human
  • Tgfb1 protein, mouse
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Vascular Endothelial Growth Factor A
  • Urokinase-Type Plasminogen Activator
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Culture Media, Conditioned (chemistry)
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms (prevention & control, secondary)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neovascularization, Pathologic (metabolism, pathology, prevention & control)
  • Pancreatic Neoplasms (blood supply, genetics, pathology)
  • Plasminogen Activator Inhibitor 1 (analysis, genetics, physiology)
  • Platelet Endothelial Cell Adhesion Molecule-1 (analysis)
  • Transfection
  • Transforming Growth Factor beta (analysis)
  • Transforming Growth Factor beta1
  • Urokinase-Type Plasminogen Activator (analysis)
  • Vascular Endothelial Growth Factor A (analysis)
  • Xenograft Model Antitumor Assays (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: